SKIN LESIONS - (Body is partly to completely cover with lesions). Causes & Conditions: Prurigo Nodularis, Lesions, Rashes, Pruritus, Staphlococcus, MRSA's, Dermatitis. Etc...

Briefly describe a specific question, or set of related questions, about a health care test or treatment that this program should consider.: SKIN LESIONS - (Body is partly to completely cover with lesions). Causes & Conditions: Prurigo Nodularis, Lesions, Rashes, Pruritus, Staphlococcus, MRSA's, Dermatitis. Etc...
Does your question include a comparison of different health care approaches? (If no, your topic will still be considered.): no
If yes, explain the specific technologies, devices, drugs, or interventions you would like to see compared:
What patients or group(s) of patients does your question apply to? (Please include specific details such as age range, gender, coexisting diagnoses, and indications for therapy.): All patients...
Are there subgroups of patients that your question might apply to? (For example, an ethnic group, stage or severity of a disease.): I don't know.
Describe the health-related benefits you are interested in. (For example, improvements in patient symptoms or problems from treatment or diagnosis.): Stop itching, Clear-up rashes and lesions. Getting your health back.
Describe any health-related risks, side effects, or harms that you are concerned about.: Infections, scaring, Breaking the cycle before it becomes Prurigo Nodularis, and covering the entire body...

Does your question include a health care drug, intervention, device, or technology available (or likely to be available) in the U.S.?

yes

Which priority area(s) and population(s) does this topic apply to? (check all that apply)

EHC Priority Conditions (updated in 2008)

AHRQ Priority Populations

Federal Health Care Program

Describe why this topic is important.: MRSA's not properly treated end up as severe Prurigo Nodularis, causing life time skin damage, itching, severe fatigue, etc...
What specifically motivated you to ask this question? (For example, you are developing a clinical guideline, working with a policy with large uncertainty about the appropriate approach, costly intervention, new research you have read, items in the media you may have seen, a clinical practice dilemma you know of, etc.): It's happening to my family. It took Kaiser's Primary Care Doctor, Dermatologist, Infectious Disease, ER Doctors approximately 10+ months to identify skin infection that ended up covering my wife's entire body with lesions.
Does your question represent uncertainty for clinicians and/or policy-makers? (For example, variations in clinical care, controversy in what constitutes appropriate clinical care, or a policy decision.): yes
If yes, please explain:: We finally were sent to Kaiser's Head of Dermatology. Dr. Crowely also works with UCSF, and published "How Staph and/or MRSAs not properly treated can end with Prurigo Nodularis, and scaring. We were initially treated for acne, and then several "Lets Try This" treatments.

How will an answer to your research question be used or help inform decisions for you or your group?: Knowledge
Describe the timeframe in which an answer to your question is needed.: ASAP
Describe any health disparities, inequities, or impact on vulnerable populations your question applies to.: I'm not sure of this question...

Other Information About You: (optional)

Please choose a description that best describes your role or perspective: (you may select more than one category if appropriate): Knowledge

Are you making a suggestion as an individual or on behalf of an organization?: Individual

Please tell us how you heard about the Effective Health Care Program: Dr. Margaret A Caudill, MD, PhD, MPH

Effective Health Care Program